Karyopharm Therapeutics Inc. (KPTI): Price and Financial Metrics
Karyopharm Therapeutics Inc. (KPTI)
Today's Latest Price: $14.84 USD
Updated Sep 25 4:00pm
Add KPTI to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 233 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
KPTI Stock Summary
- With a price/sales ratio of 13.03, Karyopharm Therapeutics Inc has a higher such ratio than 89.56% of stocks in our set.
- Revenue growth over the past 12 months for Karyopharm Therapeutics Inc comes in at 721.33%, a number that bests 98.92% of the US stocks we're tracking.
- Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for KPTI comes in at -20.09% -- higher than that of just 18.23% of stocks in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Karyopharm Therapeutics Inc are RTRX, VERU, ATNX, BLDP, and PFNX.
- KPTI's SEC filings can be seen here. And to visit Karyopharm Therapeutics Inc's official web site, go to www.karyopharm.com.
KPTI Stock Price Chart Technical Analysis Charts
KPTI Price/Volume Stats
| Current price | $14.84 | 52-week high | $29.61 |
| Prev. close | $14.70 | 52-week low | $8.91 |
| Day low | $14.40 | Volume | 2,115,291 |
| Day high | $15.17 | Avg. volume | 1,664,523 |
| 50-day MA | $15.78 | Dividend yield | N/A |
| 200-day MA | $18.18 | Market Cap | 1.09B |
Karyopharm Therapeutics Inc. (KPTI) Company Bio
Karyopharm Therapeutics is a clinical-stage pharmaceutical company focused on the discovery and development of drugs directed against nuclear transport targets for the treatment of cancer and other major diseases. The company was founded in 2008 and is based in in Newton, Massachusetts.
Loading social stream, please wait...